C
Caribou Biosciences
Berkeley, United States
Founded 2011 NASDAQ: CRBU
Cell Therapy Nano Gene Therapy Delivery Nano-Bio Synthetic Biology Nanosequencing Protein Engineering
About
Clinical-stage CRISPR genome editing company developing transformative therapies
Company Details
- Type
- public
- Employees
- 300+
- Funding
- Public
Key Products
- CB-010
- CB-011
- CB-012